CMS Directors Urge Industry To Weigh In On MCIT Innovative Tech Proposal
Rule would supply direct reimbursement pathway for FDA breakthrough devices
Executive Summary
Medicare agency reimbursement experts asked device technology firms to explain regulatory hurdles to getting proper reimbursements for their products in comments on an innovative technology rule.
You may also be interested in...
COVID-19 Flexibility For Telehealth Payments Should Be Made Permanent, Telemedicine Group Tells CMS
The American Telemedicine Association backed use of more telehealth providers and changes to remote monitoring reimbursements in comments to the US Medicare agency.
Game-Changer? CMS Proposes Rule To Cover Breakthrough Devices On Provisional Basis
The long-awaited proposed rule from the US Medicare agency would allow breakthrough products approved by the FDA to get reimbursed, while manufacturers continue to collect clinical and real-world data.
White House To Deliver 25 Million Face Masks To Low-Income Americans
The White House will be spending $86m to provide tens of millions of coronavirus masks to poorer American households.